- Home
- NEOV vs SCPH Comparison
NEOV vs SCPH Comparison
Compare NEOV & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- SCPH
- Stock Information
- Founded
- NEOV 2018
- SCPH 2013
- Country
- NEOV United States
- SCPH United States
- Employees
- NEOV N/A
- SCPH N/A
- Industry
- NEOV Industrial Machinery/Components
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NEOV Miscellaneous
- SCPH Health Care
- Exchange
- NEOV Nasdaq
- SCPH Nasdaq
- Market Cap
- NEOV 181.8M
- SCPH 160.6M
- IPO Year
- NEOV N/A
- SCPH 2017
- Fundamental
- Price
- NEOV $3.32
- SCPH $3.28
- Analyst Decision
- NEOV Strong Buy
- SCPH Strong Buy
- Analyst Count
- NEOV 1
- SCPH 2
- Target Price
- NEOV $7.50
- SCPH $15.00
- AVG Volume (30 Days)
- NEOV 314.7K
- SCPH 251.3K
- Earning Date
- NEOV 02-11-2025
- SCPH 03-12-2025
- Dividend Yield
- NEOV N/A
- SCPH N/A
- EPS Growth
- NEOV N/A
- SCPH N/A
- EPS
- NEOV N/A
- SCPH N/A
- Revenue
- NEOV $2,471,178.00
- SCPH $30,278,000.00
- Revenue This Year
- NEOV $85.10
- SCPH $173.14
- Revenue Next Year
- NEOV $281.25
- SCPH $131.01
- P/E Ratio
- NEOV N/A
- SCPH N/A
- Revenue Growth
- NEOV N/A
- SCPH 303.87
- 52 Week Low
- NEOV $0.63
- SCPH $3.08
- 52 Week High
- NEOV $6.11
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- NEOV 37.59
- SCPH 41.79
- Support Level
- NEOV $3.15
- SCPH $3.15
- Resistance Level
- NEOV $3.85
- SCPH $3.52
- Average True Range (ATR)
- NEOV 0.33
- SCPH 0.18
- MACD
- NEOV -0.05
- SCPH -0.00
- Stochastic Oscillator
- NEOV 18.12
- SCPH 15.22
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.